Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 250 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2422 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

25 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2021-09-16 2021-11-11 145791
TEVA-RISEDRONATE 30MG TABLET Resolved 2021-10-21 2021-12-17 147714
TEVA-CODEINE 30MG TABLET Resolved 2021-11-04 2022-03-09 148838
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2022-02-17 2023-02-09 155140
TEVA-AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2022-02-24 2022-04-21 155563
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Resolved 2022-04-21 2022-10-29 159186
TEVA-CODEINE 30MG TABLET Resolved 2022-07-25 2022-12-22 165436
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2022-08-18 2024-05-16 166975
TEVA-MIRTAZAPINE 30MG TABLET Resolved 2022-08-18 2022-09-08 167246
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-01 2023-02-09 176854
TEVA-MIRTAZAPINE 30MG TABLET Resolved 2022-12-22 2023-04-28 179188
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-22 2023-02-09 179303
TEVA-AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2023-02-02 2023-09-07 183419
TEVA-MIRTAZAPINE 30MG TABLET Resolved 2023-06-08 2023-10-03 194100
TEVA-AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2023-06-16 2023-07-05 195139
TEVA-MIRTAZAPINE 30MG TABLET Resolved 2023-06-19 2023-07-06 195509
TEVA-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2023-06-19 2024-03-18 195649
TEVA-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2023-06-20 2024-03-18 195879
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-04 2023-08-04 197169
TEVA-MIRTAZAPINE 30MG TABLET Actual shortage 2023-10-05 2023-11-09 206407

Showing 1801 to 1820 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
TEVA-CIPROFLOXACIN Discontinued 2018-10-12 2018-10-12 63952
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64520
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64526
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64529
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64532
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64535
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64544
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64547
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64550
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64553
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64595
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64598
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623

Showing 1 to 20 of 250